Biogen Agrees To Pay $900 Million To Settle False Claims Act Whistleblower Lawsuit
Biogen Agrees To Pay $900 Million To Settle Whistleblower Lawsuit: Biogen Inc. (“Biogen”), one of the world’s first global biotechnology companies, announced on July 20, 2022 that it had agreed to a $900 million settlement to resolve a whistleblower lawsuit filed in 2012 that accused i[...]